Physician profile
Anna M Bartley
NPI 1588350268
$2,914.17
in general payments reported to CMS, 2019-2025
34 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $531 · 2024: $1,043 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,914.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $367.67 | 2023-2025 | Tavneos, Evenity, Prolia |
| Abbvie INC. | $309.36 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.62 | 2023-2025 | Ofev, Jardiance, Cyltezo |
| Merck Sharp & Dohme LLC | $254.43 | 2023-2025 | Zerbaxa, Recarbrio, Dificid |
| Mallinckrodt Hospital Products INC. | $193.83 | 2024-2025 | Acthar |
| Lilly USA, LLC | $186.56 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $149.33 | 2023-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $145.29 | 2024-2025 | Dexcom G6 Transmitter |
| Ucb, INC. | $112.61 | 2023-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $102.95 | 2023-2025 | |
| Sobi, INC | $84.05 | 2023-2025 | |
| Pfizer INC. | $77.49 | 2023-2025 | |
| Baxter Healthcare | $76.90 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Glaxosmithkline, LLC. | $66.80 | 2023-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Paratek Pharmaceuticals, INC. | $55.05 | 2025 | Nuzyra |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.